Simon Stevens, NHS England Chief Executive, will today launch the first wave of NHS Innovation 'Test Beds', collaborations between the NHS and innovators, at the World Economic Forum in Davos. Read on for the full press release.
Chris Wormald has been appointed as the new Permanent Secretary at the Department of Health following the announcement last month that Dame Una O'Brien is to step down from the role.
The UK National Screening Committee has published 11 recommendations, including the introduction of the faecal immunochemical test (FIT) to replace the current faecal occult blood (FOB) test, non-invasive prenatal testing (NIPT), and HPV primary screening.
George Freeman MP, Minister for Life Sciences, announced today that two new NHS Genomic Medicine Centres - Yorkshire and the Humber, and West of England - have been added to the existing 11 centres that form the 100,000 Genomes Project.
Public Health England have published the second annual ESPAUR (English Surveillance Programme for Antimicrobial Utilisation and Resistance) report, which shows that overall antibiotic resistant infections increased through 2014.
The All Party Parliamentary Group for Life Sciences, for which BIVDA provides secretarial support as part of Life Sciences UK, has published a letter in the Sunday Times supporting funding calls ahead of the Comprehensive Spending Review (CSR).
The Science and Technology Committee (Commons) have today released their first report into the science budget, stating that the UK must increase science funding to keep up with competitors.
The Accelerated Access Review today published its interim findings, ahead of the full report, with more detailed recommendations, due out in April 2016. Sir Hugh Taylor sets out 5 propositions to speed up access to transformative health technology that can change the lives of NHS patients.
The Precision Medicine Catapult, led by John McKinley, today announced the locations of six initial regional centres of excellence as Belfast, Cardiff, Glasgow, Leeds, Manchester and Oxford.
Chief Executive of BIVDA, Doris-Ann Williams MBE, has responded to the Jim O'Neill Review on Antimicrobial Resistance, entitled Rapid Diagnostics: Stopping Unnecessary Use of Antibiotics.
News, Policy & Media
BIVDA Press Releases
Click here to view more of our Parliamentary Newsletters
© 2015 BIVDA Ltd is registered in England, with Company Number 2687137
Registered Office is Devonshire House (2nd floor), 164-168 Westminster Bridge Road, London, SE1 7RW VAT Number 563105858